Slide 1 Should we treat HIV Controllers ? IAS 2013 Pr Olivier Lambotte Department of internal medicine and clinical immunology Bicêtre Hospital, University Paris South Slide…
Outline Background VL role in HIV treatment monitoring VL testing situation in Kenya Barriers to VL scale-up Strategies for scale-up DBS Kenya experience Meta analysis DBS…
PowerPoint Presentation Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister…
Slide 1 Incident STIs as a biomarker for high risk sexual behavior after entering care in individuals diagnosed with acute HIV Cope AB, Crooks A, Kuruc J, Sugarbaker A, Hightow-Weidman…
Communities and research : the necessity for dialogue Bruno Spire President of AIDES Researcher at INSERM Operations research Operational research &community-based research…